Purpose

The roots of the Foundation:
Family history and values

Founded in Geneva in 2022, the Anne and Claude Berda Foundation builds on the entrepreneurial legacy of Claude, a leading figure in audiovisual media, real estate, and private equity, and on the values instilled by Anne: merit, perseverance, diligence, and hard work. Guided by this heritage, the Foundation is dedicated to fighting brain diseases by supporting pioneering medical research with a strong entrepreneurial spirit.

At a glance

Healthtech innovations bring hope to patients with brain diseases

80 %

of current R&D in the health sector is carried out by start-up companies1

90 %

of pre-clinical research projects fail before reaching the clinical phase2

4.5 M

people with brain tumors in 20213

55 M

people with dementia in 20254

152 M

people with dementia by 20504

1 Company segments as a percentage of pipeline projects and global sales in 2018, IQVIA, 2018 | 2 Clinical development success rates for investigational drugs – Nature Biotechnology, September 2016 | 3 Key Facts and Figure – World Brain Tumor Day, 2021 | 4 Dementia statistics, Azheimer’s Disease International, 2025

Goal

Contribute to cure brain diseases

Missions

Support medical research through entrepreneurship

01 02
/02

Donations
Entrepreneurial-driven projects and programs

Foster scientific excellence to translate medical research into tangible treatments for neurological disorders
  • Indirect donations: leading research institutes in Europe
  • Target areas: brain tumors and neurodegenerative diseases
  • Research stages: academic to pre-clinical
  • Funding stages: pre-seed

Investments
Biotech & Medtech startups with strong patient benefits

Leverage a network of experts and strategic partners to accelerate the discovery of groundbreaking treatments
  • Indirect Investments: biotech & medtech VC Funds in Europe
  • Target areas: patients with unmet medical needs, especially neurological diseases
  • Research stages: pre-clinical to clinical (up to Phase 3)
  • Funding stages: seed to growth